MARKET

RGEN

RGEN

Repligen Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

124.84
+2.33
+1.90%
Closed 16:13 07/14 EDT
OPEN
122.89
PREV CLOSE
122.51
HIGH
124.93
LOW
120.12
VOLUME
397.78K
TURNOVER
--
52 WEEK HIGH
143.93
52 WEEK LOW
72.32
MARKET CAP
6.53B
P/E (TTM)
277.55
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RGEN stock price target is 141.17 with a high estimate of 151.00 and a low estimate of 115.00.

EPS

RGEN News

More
Here's Why Repligen Rose 33.6% in the First Half of 2020
Motley Fool · 6d ago
LGND or RGEN: Which Is the Better Value Stock Right Now?
Zacks · 07/03 16:40
These 3 Stocks Are Potential Buyout Targets
Motley Fool · 07/03 13:34
HC Wainwright & Co. Maintains Buy on Repligen, Raises Price Target to $151
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Repligen (NASDAQ:RGEN) with a Buy and raises the price target from $143 to $151.
Benzinga · 06/30 11:01
Repligen to buy engineered molding technology firm
Seeking Alpha - Article · 06/29 16:15
Repligen Announces Agreement to Acquire Engineered Molding Technology
GlobeNewswire · 06/29 12:30
Repligen Announces Agreement To Acquire Engineered Molding Technology; Terms Not Dicslosed
Expands Single-Use Portfolio with Expertise in Silicone Molding and Tubing WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing
Benzinga · 06/29 11:34
Repligen Corporation (RGEN): Hedge Funds Taking Some Chips Off The Table
Insider Monkey · 06/18 20:32

Industry

Medical Equipment, Supplies & Distribution
+2.37%
Healthcare Equipment & Supplies
+2.31%

Hot Stocks

Symbol
Price
%Change

About RGEN

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.
More

Webull offers kinds of Repligen Corporation stock information, including NASDAQ:RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.